TITLE

Bad Ad Program: Year of Fear

PUB. DATE
July 2011
SOURCE
Pharmaceutical Representative;Jul2011, Vol. 41 Issue 7, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the launch of Bad Ad program by the U.S. Food and Drug Administration (FDA).
ACCESSION #
63483064

 

Related Articles

  • Rogue Rx Sellers Targeted.  // Chain Drug Review;3/17/2014, Vol. 36 Issue 5, p67 

    The article focuses on a report by the U.S. Government Accountability Office which revealed an estimate of 36,000 rogue Internet pharmacies that are in operation as of February 2014 and are illegally providing drugs in the U.S. which have not been approved by the U.S. Food and Drug Administration.

  • Glaxo Pleads Guilty to Health Fraud; Agrees to Pay $3 Billion in Penalties.  // MondayMorning;7/9/2012, Vol. 20 Issue 27, p1 

    The article reports on the guilty plea made by GlaxoSmithKline PLC on the U.S. healthcare fraud filed against it by the Justice Department in 2012. It says that the company agreed to pay $3 billion as settlement for the lawsuit. It notes that the company was alleged of marketing Paxil and...

  • Pharmacists' Role in Combating Fake Meds. Graham, J. Aaron // Chain Drug Review;4/27/2015, Vol. 37 Issue 7, p236 

    The article offers the author's insights on the role of pharmacists to contend against fake medicine in U.S. Topics discussed include the need of collaboration between the pharmaceutical companies, trade associations, government organizations and pharmacies to deal the issue of counterfeit drugs...

  • What's ailing J&J--and why isn't its rep hurting? Neff, Jack // Advertising Age;5/10/2010, Vol. 81 Issue 19, p4 

    The article focuses on the pharmaceutical industry and health care products company Johnson & Johnson. The company's ability to maintain its brand image as an admired corporation despite several product recalls, civil litigation over its business practices and a U.S. Food & Drug Administration...

  • Celebrating 70 Years of Enriched Grains in America. Adams, Judi // Snack Food & Wholesale Bakery;Apr2011, Vol. 100 Issue 4, p37 

    The article mentions the 70th anniversary of the establishment of the bread and flour enrichment programs of the U.S. Food and Drug Administration.

  • The FDA Approach to Defining Misleading Advertising. Jacoby, Jacob; Small, Constance // Journal of Marketing;Oct75, Vol. 39 Issue 4, p65 

    The article reports on a method used by the U.S. Food and Drug Administration (FDA) to define and assess deceptive advertising. The author focuses on misleading advertising associated with the pharmaceutical industry in the U.S. A definition of misleading advertising is provided. It is suggested...

  • The FDA Approach to Defining Misleading Advertising. Jacoby, Jacob; Small, Constance // Journal of Marketing;Oct75, Vol. 39 Issue 4, p65 

    The article reports on a method used by the U.S. Food and Drug Administration (FDA) to define and assess deceptive advertising. The author focuses on misleading advertising associated with the pharmaceutical industry in the U.S. A definition of misleading advertising is provided. It is suggested...

  • REMS: red tape, or a remedy for opioid abuse? PORADA, STEPHEN // Journal of Family Practice;Sep2011 Supplement 2, Vol. 60, pS55 

    The author discusses the Risk Evaluation and Mitigation Strategies (REMS), which is an imposed program from the U.S. Food and Drug Administration (FDA). He is critical on the reasons provided by the FDA regarding the program such as to assure that the benefits of opioid analgesics prescription...

  • The Role of the Food and Drug Administration in the Nutritional Quality of Foods. Forbes, Allan L. // American Journal of Public Health;Sep1972, Vol. 62 Issue 9, p1207 

    A review is offered of the function of the Food and Drug Administration in relation to foods and of various activities and programs now being carried on.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics